100 research outputs found
Visual Network Analysis of Dynamic Metabolic Pathways
Abstract. We extend our previous work on the exploration of static metabolic
networks to evolving, and therefore dynamic, pathways. We apply our visualization software to data from a simulation of early metabolism. Thereby, we show
that our technique allows us to test and argue for or against different scenarios for
the evolution of metabolic pathways. This supports a profound and efïŹcient analysis of the structure and properties of the generated metabolic networks and its
underlying components, while giving the user a vivid impression of the dynamics
of the system. The analysis process is inspired by Ben Shneidermanâs mantra of
information visualization. For the overview, user-deïŹned diagrams give insight
into topological changes of the graph as well as changes in the attribute set associated with the participating enzymes, substances and reactions. This way, âinteresting featuresâ in time as well as in space can be recognized. A linked view
implementation enables the navigation into more detailed layers of perspective
for in-depth analysis of individual network conïŹguration
Measurement of CP observables in B± â D(â)K± and B± â D(â)ϱ decays
Measurements of CP observables in B ± âD (â) K ± and B ± âD (â) Ï Â± decays are presented, where D (â) indicates a neutral D or D â meson that is an admixture of D (â)0 and DÂŻ (â)0 states. Decays of the D â meson to the DÏ 0 and DÎł final states are partially reconstructed without inclusion of the neutral pion or photon, resulting in distinctive shapes in the B candidate invariant mass distribution. Decays of the D meson are fully reconstructed in the K ± Ï â , K + K â and Ï + Ï â final states. The analysis uses a sample of charged B mesons produced in pp collisions collected by the LHCb experiment, corresponding to an integrated luminosity of 2.0, 1.0 and 2.0 fb â1 taken at centre-of-mass energies of s=7, 8 and 13 TeV, respectively. The study of B ± âD â K ± and B ± âD â Ï Â± decays using a partial reconstruction method is the first of its kind, while the measurement of B ± âDK ± and B ± âDÏ Â± decays is an update of previous LHCb measurements. The B ± âDK ± results are the most precise to date
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990â2016: a systematic analysis for the Global Burden of Disease Study 2016
As mortality rates decline, life expectancy increases, and populations age, non-fatal outcomes of diseases and injuries are becoming a larger component of the global burden of disease. The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016
Measurement of asymmetries in and decays
See paper for full list of authors - All figures and tables, along with any supplementary material and additional information, are available at https://lhcbproject.web.cern.ch/lhcbproject/Publications/LHCbProjectPublic/LHCb-PAPER-2016-041.html - Submitted to Phys. Lett. BInternational audienceA search for CP violation in D±âηâČϱ and D±sâηâČϱ decays is performed using proton-proton collision data, corresponding to an integrated luminosity of 3 fbâ1, recorded by the LHCb experiment at centre-of-mass energies of 7 and 8 TeV. The measured CP-violating charge asymmetries are ACP(D±âηâČϱ)=(â0.61±0.72±0.55±0.12)% and ACP(D±sâηâČϱ)=(â0.82±0.36±0.24±0.27)%, where the first uncertainties are statistical, the second systematic, and the third are the uncertainties on the ACP(D±âK0Sϱ) and ACP(D±sâÏϱ) measurements used for calibration. The results represent the most precise measurements of these asymmetries to date
Measurement of , , and production asymmetries in 7 and 8 TeV proton-proton collisions
See paper for full list of authors - All figures and tables, along with any supplementary material and additional information, are available at https://lhcbproject.web.cern.ch/lhcbproject/Publications/LHCbProjectPublic/LHCb-PAPER-2016-062.html - Submitted to Phys. Lett. B.International audienceThe B0, B0s, B+ and Î0b hadron production asymmetries are measured using a data sample corresponding to an integrated luminosity of 3.0 fbâ1, collected by the LHCb experiment in proton-proton collisions at centre-of-mass energies of 7 and 8 TeV. The measurements are performed as a function of transverse momentum and rapidity of the b hadrons within the LHCb detector acceptance. The overall production asymmetries, integrated over transverse momentum and rapidity, are also determined
Search for violation in the phase space of decays
A search for time-integrated violation in the Cabibbo-suppressed decay
\mbox{D^0\rightarrow\pi^+\pi^-\pi^+\pi^-} is performed using an unbinned,
model-independent technique known as the energy test. This is the first
application of the energy test in four-body decays. The search is performed for
-even asymmetries and, for the first time, is extended to probe the
-odd case. Using proton-proton collision data corresponding to an integrated
luminosity of 3.0 fb collected by the LHCb detector at centre-of-mass
energies of 7 TeV and 8 TeV, the world's best sensitivity to
violation in this decay is obtained. The data are found to be consistent with
the hypothesis of symmetry with a -value of in the
-even case, and marginally consistent with a -value of in
the -odd case, corresponding to a significance for non-conservation of
2.7 standard deviations.Comment: All figures and tables, along with any supplementary material and
additional information, are available at
https://lhcbproject.web.cern.ch/lhcbproject/Publications/LHCbProjectPublic/LHCb-PAPER-2016-044.htm
First observation of forward production in collisions at TeV
The decay ZâbbÂŻ is reconstructed in pp collision data, corresponding to 2 fb â1 of integrated luminosity, collected by the LHCb experiment at a centre-of-mass energy of s=8 TeV. The product of the Z production cross-section and the ZâbbÂŻ branching fraction is measured for candidates in the fiducial region defined by two particle-level b -quark jets with pseudorapidities in the range 2.220 GeV and dijet invariant mass in the range 452045 < m_{jj} < 1655462 \pm 763Z \rightarrow b \bar{b}332 \pm 46 \pm 59Z \rightarrow b \bar{b}pp$ collisions
Optical absorption spectroscopy study of the causes for color variations in natural Fe-bearing gahnite: Insights from iron valency and site distribution data
Four gahnite single crystals with variable colors from pale blue to green have been studied by a multi-analytical approach with the aim to evaluate existing assignments of optical absorption bands. Combined information from electron microprobe analyses, Mössbauer spectroscopy, IR-spectroscopy, single-crystal Xâray structure refinements, and optical absorption spectroscopy confirms the conclusions of earlier studies that the absorption bands recorded in the visible spectral region up to ~540 nm (above ~18 500 cmâ1) are related to electronic d-d transitions in tetrahedrally coordinated Fe2+. It also demonstrates that a set of absorption bands between ~550â625 nm (~16 000â18 200 cmâ1) are caused by spin-allowed and spin-forbidden d-d transitions in tetrahedrally coordinated Co2+. Two absorption bands at higher wavelengths (~680 and ~800 nm, i.e., ~14 700 and ~12 500 cmâ1) are assigned to electronic transitions in exchange coupled VIFe3+-IVFe2+ pairs and a band at ~950 nm (~10 500 cmâ1) is assigned to a spin-allowed electronic transition in VIFe2+. Low-Fe gahnite crystals owe their blue color to traces of cobalt at concentration levels in the order of 200 ppm and less, while the green color of gahnite crystals with higher Fe-contents is due to a combination of electronic ligand-metal transitions causing strong UV-absorption and electronic transitions in exchange coupled Fe2+-Fe3+ cation pairs that absorb in the red region of the visible spectrum. A detailed characterization of samples that includes cation site occupancy and iron valency data is demonstrated to be crucial for interpreting optical absorption spectra. Also electronic transitions in trace element chromophores below the detection limit of electron microprobe may participate to light absorption. All this information contribute to the comprehension of the causes of crystal color of minerals, gemstones, and ceramic pigments
Acitretin and treatment of the oral leucopplakias. A model to have an active molecules release
Aims. The aim of this study was to investigate the effectiveness of acitretin in a new topical formulation (mucoadhesive two-layer tablets) for the treatment of oral leucoplakias. Methods. Twenty-one volunteers, 16 men, five women, with oral leucoplakia (histologically diagnosed), were included in this double-blind placebo-controlled study. Patients were randomized in three groups (A, B, C) of seven patients each. Groups A and B received tablets with different in vitro release profiles, and group C subjects (controls) received tablets without acitretin. The acitretin dose was 20 mg/day (two 10 mg tablets daily). Serum aspartate aminotransferase, alanine aminotransferase, cholesterol and triglycerides were evaluated before and after treatment. At the end of therapy the concentrations of acitretin in plasma, saliva and tissue were measured by high-performance liquid chromatography. Results. At the end of the study 71% (groups A and B) of patients showed clinical remission or marked improvement. No improvement was noted in the control subjects (group C). These results were further confirmed by histological findings. There were no significant changes in laboratory values in the three groups. The acitretin concentration in plasma and tissue ranged from 0 to 50 mg with no difference between groups A and B, and it was very high in saliva (ranging from 4.9 to 43 mg) with higher concentrations in group A than in group B (due to a longer adhesion time in group A). Patients' compliance was excellent. The results show that mucoadhesive tablets of topical acitretin are efficacious in the treatment of oral leucoplakia without systemic side-effects
- âŠ